Psoriatic arthritis Trials in Mérida, Mexico
Conditions / Psoriatic arthritis / Mérida, Mexico
Clinical trials for Psoriatic arthritis investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02404350 | Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis | COMPLETED | PHASE3 |
| NCT01882439 | Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors | COMPLETED | PHASE3 |
| NCT04908189 | A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04908202 | A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs | ACTIVE_NOT_RECRUITING | — |
| NCT06671483 | A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines | RECRUITING | PHASE3 |
| NCT01877668 | Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study | COMPLETED | PHASE3 |
| NCT04908202 | A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs | ACTIVE_NOT_RECRUITING | — |
| NCT02024646 | Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis | COMPLETED | PHASE3 |
| NCT01860976 | Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis | COMPLETED | PHASE3 |
| NCT02029495 | Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis | TERMINATED | PHASE3 |